BILLERICA, Mass. (AP) _ Insulet Corp. (PODD) on Thursday reported a loss of $1.7 million in its second quarter.

On a per-share basis, the Billerica, Massachusetts-based company said it had a loss of 3 cents.

The results beat Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.

The maker of insulin infusion systems posted revenue of $124.3 million in the period, falling short of Street forecasts. Ten analysts surveyed by Zacks expected $132.9 million.

For the current quarter ending in October, Insulet said it expects revenue in the range of $144.5 million to $151.5 million.

The company expects full-year revenue in the range of $547 million to $562 million.

Insulet shares have risen 26 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $87.19, an increase of 73 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PODD at https://www.zacks.com/ap/PODD